... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapyin non smallcelllung cancer: a meta-analysis ... cisplatin-teniposide in patients withadvanced non -small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141.7. ... paclitaxel plus gemcitabine in advanced non -small- cell lung cancer: a phase III trial of the European Organiza-tion for Research and Treatment of CancerLung Cancer Group – EORTC 08975. J Clin Oncol...
... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... ofdetecting EGFR mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor ... ofEGFR mutations in non -small- celllung cancer. Clin Cancer Res 2009,15:3023-3028.13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung adenocarcinoma: modification...
... are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer are associated with smoking, although ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,97:1558-1563.11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. LungCancer 2009, 65:13-18.12. ... oesophagus, head andneck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate thehypothesis of HPV involvement in smallcelllungcancer pathogenesis...
... marker expression in tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... innon -small celllung cancer. Clin Cancer Res 2008, 14:5220-7.30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts ofhypoxic markers according to NSCLC histology. LungCancer ... chemotherapy aftercomplete resection of non -small celllung carcinoma. Cancer Res 2010,70:8288-98.19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: what now? J ThoracOncol 2009, 4:671-3.20....
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... for Research and Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non -Small CellLung Can-cer;...
... gefitinib in non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients ... cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for ... in non -small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non -small- celllung cancer...
... Napoli1, Giacomo Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, ... induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, ... few cycles should notautomatically discourage to continue treatment. IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity....
... advanced non -small celllungcancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT).Methods: We analyzed 94 LANSCLC patients treated with concurrent chemotherapy ... these two modalities [2-4]. Concurrent chemoradiotherapy has become a standard method forthe management of unresectable locally advanced non- small celllungcancer (NSCLC). Unfortunately, the ... clinical and dosimetric factors associated with treatment- related pneumonitis (TRP) in patients with non -small- celllungcancer (NSCLC) treated with concurrent chemotherapy and three-dimensional...
... non -small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non -small celllung ... non -small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small celllung ... (SBRT) for lung t umorswasintroducedinthemid1990s[1],andithasbeenperformed in many institutions as a new treatment modality for stage I primary lungcancer and oligometa-static lung cancer. Promising...
... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... Okunieff2and Michael T Milano1*AbstractBackground: Standard therapy for metastatic non smallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies ... Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non -small celllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul...
... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... radiotherapy for stage Inon -small celllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana university ... nonsurgical treatment options for stage Inon -small celllung cancer. Oncologist 2008, 13:309-319.41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:Review of Hypofractionated Small...
... energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non -small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse P, ... response to treatment in solid tumors. European Organization forResearch and Treatment of Cancer, National Cancer Insti-tute of the United States, National Cancer Institute of Can-ada. J Natl Cancer ... in non -small celllung cancer Erik P Sulman, Ritsuko Komaki, Ann H Klopp, James D Cox and Joe Y Chang*Address: Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer...
... trial comparing two types of consolidationchemotherapy after concurrent chemoradiotherapy for limited-disease smallcelllung cancer. RTrequirements included a total dose of 45 Gy/30 fx (bis ... trial comparingtwo types of consolidation chemotherapy after concurrent chemoradiotherapy for limited-disease smallcell lung cancer (Figure 1).The primary endpoint of JCOG 0202 was overall ... for Cancer Control and Information Services, National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and 3JCOG lungcancer study group, Thoracic Oncology Division, National Cancer...
... megavoltage CT imaging during exter-nal beam radiotherapy for non -small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol Biol Phys 2005, 63:1024-1028.10. ... registration (DR)for adaptive radiotherapy of non -small celllungcancer (NSCLC).Methods: Based on 13 patients with locally advanced NSCLC, CT images acquired at treatment planning, midway and the end ... relationshipbetween the target and the parotid glands [8]. Similarfindings were made for non -small- celllung cancer (NSCLC), where a continuous tumor regression duringradiotherapy was observed [9].This...